Post-thoracoscopic surgery pain
Conditions
Interventions
Oxycodone group (O group):Intraoperative and postoperative use of oxycodone for analgesia
Sufentanil group (S group):Analgesic use of sufentanil during and after surgery
Sponsors
none
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-80 years old; 2. Patients with ASA class I-IV undergoing thoracoscopic surgery for chest diseases and requiring postoperative analgesia; 3. Obtain informed consent from the patient and sign the consent form
Exclusion criteria
Exclusion criteria: 1. Patients with abnormal blood coagulation function and low immune ability; 2. Patients with local infection at the nerve block puncture site and patients with severe spinal deformity; 3. Allergic to anesthetic drugs used during the perioperative period, including oxycodone and sufentanil; 4. Preoperative chronic pain attacks exist; 5.Patients with chest wall metastasis found before and during the operation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS score within 48 hours after surgery (including physical and visceral pain);The incidence of postoperative nausea and vomiting at 48 hours; | — |
Secondary
| Measure | Time frame |
|---|---|
| Autonomous mobility of patients after getting out of bed within 48 hours after surgery;QoA 15 scoring scale within 48 hours after surgery;Incidence rate and pain score of chronic pain within half a year after operation;Patient's recovery of exhaust and bowel movements within 48 hours after surgery;The number of patients who received analgesics within 48 hours after surgery, the dosage of the drugs used for relief, and patient satisfaction with pain relief; | — |
Countries
China
Contacts
Public ContactWang Yan
Nanjing Drum Tower Hospital
Outcome results
None listed